254 related articles for article (PubMed ID: 25939382)
1. RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.
Bakkar N; Kousari A; Kovalik T; Li Y; Bowser R
Mol Cell Biol; 2015 Jul; 35(14):2385-99. PubMed ID: 25939382
[TBL] [Abstract][Full Text] [Related]
2. RBM45 competes with HDAC1 for binding to FUS in response to DNA damage.
Gong J; Huang M; Wang F; Ma X; Liu H; Tu Y; Xing L; Zhu X; Zheng H; Fang J; Li X; Wang Q; Wang J; Sun Z; Wang X; Wang Y; Guo C; Tang TS
Nucleic Acids Res; 2017 Dec; 45(22):12862-12876. PubMed ID: 29140459
[TBL] [Abstract][Full Text] [Related]
3. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis.
Sarlette A; Krampfl K; Grothe C; Neuhoff Nv; Dengler R; Petri S
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1055-62. PubMed ID: 18957896
[TBL] [Abstract][Full Text] [Related]
4. Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.
Li Y; Collins M; An J; Geiser R; Tegeler T; Tsantilas K; Garcia K; Pirrotte P; Bowser R
Brain Res; 2016 Sep; 1647():79-93. PubMed ID: 26979993
[TBL] [Abstract][Full Text] [Related]
5. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
[TBL] [Abstract][Full Text] [Related]
6. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
Collins M; Li Y; Bowser R
Acta Neuropathol Commun; 2020 Jun; 8(1):91. PubMed ID: 32586379
[TBL] [Abstract][Full Text] [Related]
7. RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.
Li Y; Collins M; Geiser R; Bakkar N; Riascos D; Bowser R
Sci Rep; 2015 Sep; 5():14262. PubMed ID: 26391765
[TBL] [Abstract][Full Text] [Related]
8. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice.
Mimoto T; Miyazaki K; Morimoto N; Kurata T; Satoh K; Ikeda Y; Abe K
Brain Res; 2012 Mar; 1446():109-18. PubMed ID: 22353756
[TBL] [Abstract][Full Text] [Related]
9. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases.
Tanji K; Maruyama A; Odagiri S; Mori F; Itoh K; Kakita A; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2013 Jan; 72(1):18-28. PubMed ID: 23242280
[TBL] [Abstract][Full Text] [Related]
10. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
11. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
Niebrój-Dobosz I; Dziewulska D; Kwieciński H
Folia Neuropathol; 2004; 42(3):151-6. PubMed ID: 15535033
[TBL] [Abstract][Full Text] [Related]
12. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
Bergström P; von Otter M; Nilsson S; Nilsson AC; Nilsson M; Andersen PM; Hammarsten O; Zetterberg H
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):130-7. PubMed ID: 24102512
[TBL] [Abstract][Full Text] [Related]
13. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?
van den Heuvel DM; Harschnitz O; van den Berg LH; Pasterkamp RJ
Trends Mol Med; 2014 Jan; 20(1):25-35. PubMed ID: 24140266
[TBL] [Abstract][Full Text] [Related]
14. A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS.
Liu YJ; Kuo HC; Chern Y
Neurobiol Dis; 2021 Dec; 160():105531. PubMed ID: 34634461
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.
Ayaki T; Ito H; Fukushima H; Inoue T; Kondo T; Ikemoto A; Asano T; Shodai A; Fujita T; Fukui S; Morino H; Nakano S; Kusaka H; Yamashita H; Ihara M; Matsumoto R; Kawamata J; Urushitani M; Kawakami H; Takahashi R
Acta Neuropathol Commun; 2014 Dec; 2():172. PubMed ID: 25492614
[TBL] [Abstract][Full Text] [Related]
16. FAC1 expression and localization in motor neurons of developing, adult, and amyotrophic lateral sclerosis spinal cord.
Mu X; Springer JE; Bowser R
Exp Neurol; 1997 Jul; 146(1):17-24. PubMed ID: 9225734
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons.
Mu X; He J; Anderson DW; Trojanowski JQ; Springer JE
Ann Neurol; 1996 Sep; 40(3):379-86. PubMed ID: 8797527
[TBL] [Abstract][Full Text] [Related]
18. Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy.
Bono S; Feligioni M; Corbo M
Mol Neurodegener; 2021 Oct; 16(1):71. PubMed ID: 34663413
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
Calingasan NY; Chen J; Kiaei M; Beal MF
Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
[TBL] [Abstract][Full Text] [Related]
20. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
